TSPO and glioblastoma: It is already known that BPA is non-uniformly distributed in gliomas when BPA is administered [13,14,15,16], and furthermore, glioblastoma has proven inter-individual heterogeneity of TSPO and LAT1 expression in neoplastic and parenchymal cells [40].